humanized mice model market size, share & forecast 2025

MARKET INTELLIGENCE . CONSULTINGwww.techsciresearch.com

GLOBAL HUMANIZED MICE MODEL MARKET

FORECAST & OPPORTUNITIES

2015 – 2025

2

Scope of ReportProduct of Interest (POI): Humanized Mice Model

Review Period

2015 – 2018

Base Year

2019

Estimated Year

2020

Forecast Period

2021 – 2025

Year Range

REGION

• Asia-Pacific

• Europe

• North America

• Rest of World

Global humanized mice model market is projected to grow at a CAGR of more than 10%during 2020 - 2025. The global humanized mice model market is driven by continuousresearch and development activities in pharmaceutical companies across the globe. Inaddition to this, increasing investments for research in laboratories and institutes ispositively impacting the growth of market.

Market SegmentationTYPE

• Cell-line

transplantation model

• Patient based

xenografts

• Genetically Engineered

Mice

• Others

• Breeding

• Model In-Licensing

• Genetic Testing

• Other Services

SERVICE

IMMUNE CHECKPOINTS

• PD-1

• CTLA-4

• CD-39

• Others

• Immuno-Oncology

Studies

• Diabetes Studies

• Cardiovascular Studies

• Central Nervous

System (CNS) Studies

• Other Type Studies

APPLICATION

• Companies

(Pharmaceutical,

BioService)

• Academic and

Research Institutes

• Contract Research

Organizations

END USER

3

Table of Contents

S. No. Contents Page No.

1. Product Overview (Definition of product and major terminologies used in the report)

2.Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)

3. Impact of COVID-19 on Global Humanized Mice Model Market

4. Executive Summary

5. Voice of Customer

5.1. Factors Influencing Purchase Decision

5.2. Brand Recall

5.3. Challenges/Unmet Needs

6. Global Humanized Mice Model Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Service (Breeding, Model In-Licensing, Genetic Testing, Other Services)

6.2.2.By Type (Cell-line transplantation model, Patient based xenografts, Genetically Engineered Mice, Others)

6.2.3.By Application (Immuno-Oncology Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Other Type Studies)

6.2.4. By Immune Checkpoints (PD-1, CTLA-4, CD-39, Others)

6.2.5.By End User (Companies, Academic and Research Institutes, Contract Research Organizations)

6.2.6. By Region (Asia-Pacific, Europe, North America, Rest of the World)

4

Table of Contents


6.2.7. By Company

6.3. Product Market Map

7. Asia-Pacific Humanized Mice Model Market Outlook


7.1.1. By Value


7.2.1. By Service

7.2.2. By Type

7.2.3. By Application

7.2.4. By Immune Checkpoints

7.2.5. By End User

7.2.6. By Country (China, India, Australia, Japan, South Korea)

7.3. Asia-Pacific: Country Analysis

7.3.1. China Humanized Mice Model Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Service

7.3.1.2.2. By Type

7.3.1.2.3. By Application

5

Table of Contents


7.3.1.2.4. By End User

7.3.2. India Humanized Mice Model Market Outlook


7.3.2.1.1. By Value



7.3.2.2.2. By Type



7.3.3. Australia Humanized Mice Model Market Outlook


7.3.3.1.1. By Value



7.3.3.2.2. By Type



7.3.4. Japan Humanized Mice Model Market Outlook


7.3.4.1.1. By Value

6

Table of Contents




7.3.4.2.2. By Type



7.3.5. South Korea Humanized Mice Model Market Outlook


7.3.5.1.1. By Value



7.3.5.2.2. By Type



8. Europe Humanized Mice Model Market Outlook


8.1.1. By Value


8.2.1. By Service

8.2.2. By Type


7

Table of Contents



8.2.5. By End User

8.2.6. By Country (France, Germany, United Kingdom, Italy, Spain)

8.3. Europe: Country Analysis

8.3.1. France Humanized Mice Model Market Outlook


8.3.1.1.1. By Value



8.3.1.2.2. By Type



8.3.2. Germany Humanized Mice Model Market Outlook


8.3.2.1.1. By Value



8.3.2.2.2. By Type



8

Table of Contents


8.3.3. United Kingdom Humanized Mice Model Market Outlook


8.3.3.1.1. By Value



8.3.3.2.2. By Type



8.3.4. Italy Humanized Mice Model Market Outlook


8.3.4.1.1. By Value



8.3.4.2.2. By Type



8.3.5. Spain Humanized Mice Model Market Outlook


8.3.5.1.1. By Value


9

Table of Contents



8.3.5.2.2. By Type



8.3.6. Russia Humanized Mice Model Market Outlook


8.3.6.1.1. By Value



8.3.6.2.2. By Type



9. North America Humanized Mice Model Market Outlook


9.1.1. By Value


9.2.1. By Service

9.2.2. By Type



10

Table of Contents


9.2.5. By End User

9.2.6. By Country (United States, Canada, Mexico)

9.3. North America: Country Analysis

9.3.1. United States Humanized Mice Model Market Outlook


9.3.1.1.1. By Value



9.3.1.2.2. By Type



9.3.2. Canada Humanized Mice Model Market Outlook


9.3.2.1.1. By Value



9.3.2.2.2. By Type



9.3.3. Mexico Humanized Mice Model Market Outlook

11

Table of Contents



9.3.3.1.1. By Value



9.3.3.2.2. By Type



10. Rest of World Humanized Mice Model Market Outlook


10.1.1. By Value


10.2.1. By Service

10.2.2. By Type


10.2.4 By Immune Checkpoints

10.2.5. By End User

10.2.6. By Country (Brazil, South Africa, Israel)

10.3. Rest of World: Country Analysis

10.3.1. Brazil Humanized Mice Model Market Outlook


12

Table of Contents


10.3.1.1.1 By Value



10.3.1.2.2. By Type


10.3.1.2.4. By End User

10.3.2. South Africa Humanized Mice Model Market Outlook


10.3.2.1.1 By Value



10.3.2.2.2. By Type


10.3.2.2.4. By End User

10.3.3. Israel Humanized Mice Model Market Outlook


10.3.3.1.1 By Value



10.3.2.2.2. By Type

13

Table of Contents


11. Market Dynamics (This chapter assesses the major demand drivers and restraints.)

11.1. Drivers

11.2. Challenges

12.Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)

13. Competitive Landscape

13.1. Competition Outlook

13.2. Company Profiles

13.2.1. Company Details

13.2.2. Products & Services

13.2.3. Financials (As Reported)

13.2.4. Key Market Focus and Geographical Presence

13.2.5. Planned Investments

13.2.6. Market Positioning

13.3. Leading Players Profiled

14.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)

15. About Us & Disclaimer


10.3.2.2.4. By End User

RESEARCH METHODOLOGY

15

Research Methodology

✓ Identifying Key Opinion

Leaders

✓ Questionnaire Design

✓ In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to

determine top players in the global humanized mice

model market, overall market size and segmental

market size.

In order to conduct industry experts’

interviews, TechSci formulated a detailed

discussion guide.

List of industry players and industry

specialists was developed.

TechSci conducted interviews with

industry experts and industry players for data collection and

verification.

Data obtained as a result of primary and secondary research was

validated through rigorous

triangulation.

The data was scrutinized using MS-Excel, statistical

tools and internal proprietary database to obtain qualitative and

quantitative insights about the global humanized mice

model market.

Data

Collection

Data Filter

& AnalysisResearch &

Intelligence

Actionable

InsightsBusiness

Solution

Primary Research Desk Research Company Analysis

✓ Recent Developments

✓ Market Changing

Aspects/Dynamics

✓ Government Policies

✓ Conclusion

✓ Market Participants

✓ Key Strengths

✓ LinkedIn✓ TechSci Internal

Database

✓ Factiva✓ Hoovers

Paid Sources

✓ Company Websites✓ Company Annual

Reports✓ White Paper Study✓ Financial Reports✓ Investor

Presentations✓ Regulatory Body✓ Associations, etc.

Secondary Research

Primary Research

16


Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of the global humanized mice model market. The team has

analyzed the outlook of various segments of this market, while considering the major influencing factors such as continuous research and development

activities in pharmaceutical companies. The study includes market forecasting, which would enable our clients to take better decisions while planning

their strategy to achieve sustainability in the global humanized mice model market.

Methodology Followed for Calculation of Market Size:

• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through exhaustive

secondary research and primary surveys, with various key opinion leaders/stakeholders, such as humanized mice model companies, channel

partners, market influencers & end-users, industry experts, and other industry participants.

• The team interviewed more than 15 – 20 humanized mice model companies, 100 – 120 end-users, and 15 – 20 industry experts and other value

chain stakeholders in the global humanized mice model market to obtain the overall market size from 2015 to 2019, which was validated by the

Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-

2019.

17


• Respondents were asked about the current and future market growth rates, market shares by service, by type, by application, by immune

checkpoints, by end user, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise

revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various

segments were further triangulated from other stakeholders.

Methodology Followed for Calculation of Market Shares:

Market share by service, by type, by application, by immune checkpoints, by end user, by company and by region were calculated based on the

responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated

from various segments of humanized mice model market. The final shares were calculated by taking the geometric mean of the responses gathered

from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in

SPSS/Tableau Software.

• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global humanized

mice model market, TechSci Research used various forecast techniques such as:

✓ Moving Average

✓ Time Series Analysis

✓ Regression Analysis

✓ Econometric and Judgmental Analysis

18


TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used

the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that

the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD),

with the market size indicated in USD million.

Partial List of Companies Interviewed Key Secondary Sources

• Charles River Laboratories, International, Inc.

• The Jackson Laboratory

• Gempharmatech Co Ltd

• Taconic Biosciences, Inc.

• Envigo (Harlan Laboratories, Inc.)

• Laboratory Corporation of America Holdings

• Janvier Labs

• Trans Genic, Inc.

• Genoway

• Creative Biolabd

• Horizon Discovery Group

• Ingenious Targeting Laboratory

• Biocytogen

• Taconic Biosciences

• World Bank

• TechSci Research Proprietary Database & Knowledge Repository

• Company Annual Reports

• Industry Magazines

• Industry Reports

• News Dailies

• Credible Paid Databases

19

Industry Brief

According to TechSci Research report, “Global Humanized Mice Model Market By Service, By Type, By Immune Checkpoints, By Application, By

End-user, By Region, Competition, Forecast & Opportunities, 2025”, the global humanized mice model market is projected to grow at a CAGR of

10% during the forecast period on account of expanding pipeline of pharmaceutical and biopharmaceutical companies across the globe. Besides,

growing application of mice model for research purpose such as for immunology and inflammation studies, central nervous system studies,

among others, is further expected to fuel the market growth. Moreover, growing rising demand for mice model in cancer research so that genetic

basis of tumor development and cancer progression can be studied, is further driving the market. However, there are certain factors that might

act as major impediments to the growth of global mice model market during the forecast period such as growing concern for the wellbeing of

animals coupled with increasing awareness pertaining to animal rights.

Based on the application, the market is segmented into immune-oncology, central nervous system, cardiovascular, diabetes and others. The

immune-oncology segment accounted for the largest market share in 2019 and the segment is expected to maintain its market dominance during

the forecast period as well due to the growing rate of cancer cases and increasing investments on immune-oncology research. Based on type,

the market is fragmented into cell line transplantation model, patient derived xenografts, genetically engineered mouse model and others. Out of

these segments, the cell transplantation model segment dominated the market until 2019, genetically engineered mouse model and patient

derived xenografts segments.

Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan

Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd, Horizon Discovery

Group, Ingenious Targeting Laboratory, Biocytogen, Taconic Biosciences are some of the leading players operating in global humanized mice

model market. “North America is expected to dominate the humanized mice model market during the forecast period owing to surging focus on

biomedical research in the region, predominantly in the United States. Additionally, rising demand for monoclonal antibody production is further

expected to spur the market growth.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management

consulting firm.

20

Sample Data - Snapshot

Figure XX: Global Humanized Mice Model Market Size, By Value (USD Million), 2015-2025F

5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00

2015 2019 2020E 2025F

By Value (USD Million)

CAGR By Value CAGR By Value

XX% YY%

North America Humanized Mice Model Market Share, By Service, By Value, 2015–2025F

25%25%25%25%25%25%25%25%25%25%25%

25%25%25%25%25%25%25%25%25%25%25%

25%25%25%25%25%25%25%25%25%25%25%

25%25%25%25%25%25%25%25%25%25%25%

2015

2016

2017

2018

2019

2020E

2021F

2022F

2023F

2024F

2025F

Breeding Model In-Licensing Genetic Testing Other Services

Canada Humanized Mice Model Market Share, By Type, By Value, 2015–2025F

30%30%

30%

30%

30%

30%

30%

30%

30%

30%

30%

20%20%

20%

20%

20%

20%

20%

20%

20%

20%

20%

30%30%

30%

30%

30%

30%

30%

30%

30%

30%

30%

20%20%

20%

20%

20%

20%

20%

20%

20%

20%

20%

2015

2016

2017

2018

2019

2020E

2021F

2022F

2023F

2024F

2025F

Cell-line transplantation model Patient based xenografts Genetically Engineered Mice Others

21

Report Ordering

Report Name: GLOBAL HUMANIZED MICE MODEL MARKET

FORECAST & OPPORTUNITIES

2015 – 2025

To View Sample OR Purchase Report

License Type Price

Single User License $4450

Multi-User License $5450

Custom Research License $9450

https://www.techsciresearch.com/report/humanized-mice-model-market/4827.html

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas

to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting

Modes use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and

global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the

market.

Related Reports

• Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product

(Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025

• Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management,

Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Type (Disposable and Reusable), By End User

(Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or

complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand.

However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results

obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together

with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal

consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America708 Third Avenue, Manhattan,

New York, United States

Tel: +1- 646- 360- 1656

Email: [email protected]

www.techsciresearch.com

Disclaimer

TechSci Research – Europe54, Old brook, Bretton,

Peterborough,

United Kingdom



TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital

Region, U.P. - India

Tel: +91-120-4523900



humanized mice model market size, share & forecast 2025

Healthcare

humanized mice model market

mice model market size